https://bay85-3934modulator.co....m/recent-improvement
Treatment type did not influence sarcopenia's association with radiographic progression (adjusted hazard ratio [aHR] = 2.39; 95% confidence interval [CI] = 1.06-5.36; p = 0.0035) or overall mortality (aHR = 2.44; 95% CI = 1.17-5.08; p = 0.0018). Radiographic progression and mortality in men with mCRPC are linked to baseline sarcopenia, irrespective of treatment type. This correlation extends to potentially severe treatment-related toxicities and increased em
پسند
تبصرہ
بانٹیں
